SWSAP1
gene geneOn this page
Also known as FLJ35119ZSWIM7AP1SWS1AP1
Summary
SWSAP1 (SWIM-type zinc finger 7 associated protein 1, HGNC:26638) is a protein-coding gene on chromosome 19p13.2, encoding ATPase SWSAP1 (Q6NVH7). ATPase which is preferentially stimulated by single-stranded DNA and is involved in homologous recombination repair (HRR).
Enables ATP hydrolysis activity and single-stranded DNA binding activity. Involved in double-strand break repair via homologous recombination and protein stabilization. Part of Shu complex.
Source: NCBI Gene 126074 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 39 total
- MANE Select transcript:
NM_175871
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26638 |
| Approved symbol | SWSAP1 |
| Name | SWIM-type zinc finger 7 associated protein 1 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35119, ZSWIM7AP1, SWS1AP1 |
| Ensembl gene | ENSG00000173928 |
| Ensembl biotype | protein_coding |
| OMIM | 614536 |
| Entrez | 126074 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000312423, ENST00000674460, ENST00000884600
RefSeq mRNA: 1 — MANE Select: NM_175871
NM_175871
CCDS: CCDS12259
Canonical transcript exons
ENST00000674460 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001186021 | 11374666 | 11374929 |
| ENSE00003898849 | 11375513 | 11376169 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 84.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5299 / max 43.3160, expressed in 1441 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173916 | 3.5299 | 1441 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.87 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.94 | gold quality |
| monocyte | CL:0000576 | 82.83 | gold quality |
| leukocyte | CL:0000738 | 82.52 | gold quality |
| granulocyte | CL:0000094 | 80.45 | gold quality |
| right lobe of liver | UBERON:0001114 | 78.74 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.44 | gold quality |
| spleen | UBERON:0002106 | 78.11 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.91 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.88 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 76.93 | gold quality |
| left adrenal gland | UBERON:0001234 | 76.92 | gold quality |
| apex of heart | UBERON:0002098 | 76.38 | gold quality |
| adrenal cortex | UBERON:0001235 | 76.23 | gold quality |
| metanephros cortex | UBERON:0010533 | 76.17 | gold quality |
| blood | UBERON:0000178 | 76.15 | gold quality |
| right uterine tube | UBERON:0001302 | 74.90 | gold quality |
| adrenal gland | UBERON:0002369 | 74.37 | gold quality |
| metanephros | UBERON:0000081 | 74.20 | gold quality |
| transverse colon | UBERON:0001157 | 73.70 | gold quality |
| body of stomach | UBERON:0001161 | 73.69 | gold quality |
| right coronary artery | UBERON:0001625 | 73.67 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.47 | gold quality |
| left coronary artery | UBERON:0001626 | 73.38 | gold quality |
| lymph node | UBERON:0000029 | 73.18 | gold quality |
| left uterine tube | UBERON:0001303 | 72.84 | gold quality |
| coronary artery | UBERON:0001621 | 72.80 | gold quality |
| gastrocnemius | UBERON:0001388 | 72.74 | gold quality |
| cerebellar vermis | UBERON:0004720 | 72.74 | gold quality |
| bone marrow | UBERON:0002371 | 72.56 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.80 |
| E-MTAB-7303 | no | 331.75 |
| E-GEOD-110499 | no | 50.04 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
44 targeting SWSAP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-130A-3P | 99.90 | 73.31 | 1861 |
| HSA-MIR-130B-3P | 99.90 | 73.27 | 1850 |
| HSA-MIR-301A-3P | 99.90 | 73.15 | 1839 |
| HSA-MIR-301B-3P | 99.90 | 73.19 | 1836 |
| HSA-MIR-3666 | 99.90 | 73.24 | 1833 |
| HSA-MIR-4295 | 99.90 | 73.11 | 1838 |
| HSA-MIR-8076 | 99.78 | 68.52 | 1170 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6512-3P | 99.65 | 66.07 | 1468 |
| HSA-MIR-6720-5P | 99.65 | 66.22 | 1459 |
| HSA-MIR-4502 | 99.65 | 66.99 | 1021 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-802 | 99.61 | 67.70 | 1254 |
| HSA-MIR-142-5P | 99.48 | 70.92 | 2416 |
| HSA-MIR-5590-3P | 99.48 | 70.91 | 2429 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
Literature-anchored findings (GeneRIF, showing 4)
- the human Shu complex (hSWS1.SWSAP1) has an evolutionarily conserved function in homologous recombination (PMID:21965664)
- SWSAP1 protects RAD51 filaments by antagonizing the anti-recombinase, FIGNL1. (PMID:30926776)
- our study uncovers a protein complex, which consists of SWS1, SWSAP1, SPIDR and PDS5B, involved in DNA repair and provides insight into Shu complex function and composition. (PMID:31665741)
- The human Shu complex promotes RAD51 activity by modulating RPA dynamics on ssDNA. (PMID:39169038)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Swsap1 | ENSMUSG00000051238 |
| rattus_norvegicus | Swsap1 | ENSRNOG00000012604 |
Protein
Protein identifiers
ATPase SWSAP1 — Q6NVH7 (reviewed: Q6NVH7)
Alternative names: SWIM-type zinc finger 7-associated protein 1, SWS1-associated protein 1, ZSWIM7-associated protein 1
All UniProt accessions (2): Q6NVH7, A0A6I8PRB2
UniProt curated annotations — full annotation on UniProt →
Function. ATPase which is preferentially stimulated by single-stranded DNA and is involved in homologous recombination repair (HRR). Has a DNA-binding activity which is independent of its ATPase activity.
Subunit / interactions. Interacts with ZSWIM7; they form a functional complex involved in homologous recombination repair and stabilize each other. Interacts with RAD51, RAD51B, RAD51C, RAD51D and XRCC3; involved in homologous recombination repair.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_787067* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
UniProt features (6 total): mutagenesis site 2, chain 1, region of interest 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6NVH7-F1 | 83.34 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 18 | loss of function in hrr associated with altered ssdna-stimulated atpase activity. |
| 96 | loss of function in hrr associated with altered ssdna-stimulated atpase activity. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 83 (showing top):
MARTINEZ_RB1_TARGETS_UP, GOBP_PROTEIN_STABILIZATION, GOBP_DNA_DAMAGE_RESPONSE, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOBP_RECOMBINATIONAL_REPAIR, MARTINEZ_RB1_AND_TP53_TARGETS_UP, GOMF_SINGLE_STRANDED_DNA_BINDING, RFX1_01, chr19p13, GOBP_DNA_METABOLIC_PROCESS, GOBP_DNA_REPAIR, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, ATGGYGGA_UNKNOWN, GOBP_DNA_RECOMBINATION, DODD_NASOPHARYNGEAL_CARCINOMA_DN
GO Biological Process (5): double-strand break repair via homologous recombination (GO:0000724), protein stabilization (GO:0050821), DNA repair (GO:0006281), DNA recombination (GO:0006310), DNA damage response (GO:0006974)
GO Molecular Function (4): single-stranded DNA binding (GO:0003697), ATP hydrolysis activity (GO:0016887), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), Shu complex (GO:0097196)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA metabolic process | 2 |
| recombinational repair | 1 |
| double-strand break repair | 1 |
| regulation of protein stability | 1 |
| DNA damage response | 1 |
| cellular response to stress | 1 |
| DNA binding | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| ATP-dependent activity | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
439 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SWSAP1 | SPIDR | Q14159 | 753 |
| SWSAP1 | ZSWIM7 | Q19AV6 | 749 |
| SWSAP1 | XRCC3 | O43542 | 711 |
| SWSAP1 | K7EN88 | K7EN88 | 671 |
| SWSAP1 | RAD51D | O75771 | 671 |
| SWSAP1 | PDS5B | Q9NTI5 | 654 |
| SWSAP1 | MEIOB | Q8N635 | 642 |
| SWSAP1 | RAD51B | O15315 | 622 |
| SWSAP1 | FIGNL1 | Q6PIW4 | 571 |
| SWSAP1 | RMND5A | Q9H871 | 556 |
| SWSAP1 | RAD51C | O43502 | 555 |
| SWSAP1 | HSF2BP | O75031 | 534 |
| SWSAP1 | BRCA2 | P51587 | 531 |
| SWSAP1 | XRCC2 | O43543 | 489 |
| SWSAP1 | CCDC159 | P0C7I6 | 479 |
IntAct
54 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZSWIM7 | SWSAP1 | psi-mi:“MI:0915”(physical association) | 0.900 |
| SWSAP1 | ZSWIM7 | psi-mi:“MI:0915”(physical association) | 0.900 |
| SWSAP1 | SPIDR | psi-mi:“MI:0915”(physical association) | 0.720 |
| SPIDR | SWSAP1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SPIDR | SWSAP1 | psi-mi:“MI:0914”(association) | 0.720 |
| SPIDR | ZSWIM7 | psi-mi:“MI:0915”(physical association) | 0.660 |
| ZSWIM7 | SPIDR | psi-mi:“MI:0915”(physical association) | 0.660 |
| SWSAP1 | SPG21 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SWSAP1 | EPM2AIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SWSAP1 | GAPDHS | psi-mi:“MI:0914”(association) | 0.530 |
| PLA2G10 | CHEK1 | psi-mi:“MI:0914”(association) | 0.530 |
| REEP1 | PLSCR1 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (54): SWSAP1 (Two-hybrid), ZSWIM7 (Affinity Capture-MS), SWSAP1 (Affinity Capture-MS), GAPDHS (Affinity Capture-MS), UBB (Affinity Capture-MS), SWSAP1 (Affinity Capture-Western), SWSAP1 (Affinity Capture-Western), FIGNL1 (Synthetic Rescue), ZSWIM7 (Two-hybrid), SWSAP1 (Two-hybrid), SWSAP1 (Two-hybrid), EPM2AIP1 (Two-hybrid), ZSWIM7 (Two-hybrid), UBB (Affinity Capture-MS), GAPDHS (Affinity Capture-MS)
ESM2 similar proteins: A4GXA9, A7E3N7, A8VU90, D3KCC4, D3ZZN9, G3V8H4, O08672, O95382, Q13608, Q13671, Q14296, Q17RN3, Q28616, Q3UR50, Q3UR97, Q3V3V9, Q4KM32, Q53GL7, Q56A04, Q58CQ5, Q58EX7, Q5BK61, Q5NVA9, Q62893, Q643R3, Q66H85, Q6F5E8, Q6NVH7, Q6ZW31, Q7T0L4, Q80UU1, Q80XL1, Q8BJW7, Q8BTN6, Q8CIE4, Q8CJ00, Q8K592, Q8N2G8, Q8NAG6, Q8VCI7
Diamond homologs: Q6NVH7, Q8VCI7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SWSAP1 | “form complex” | “SHU complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 5 | 123.1× | 5e-09 |
| Homologous DNA Pairing and Strand Exchange | 5 | 119.0× | 5e-09 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | 6 | 112.7× | 4e-10 |
| Presynaptic phase of homologous DNA pairing and strand exchange | 6 | 102.0× | 4e-10 |
| HDR through Homologous Recombination (HRR) | 6 | 71.4× | 3e-09 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| double-strand break repair via homologous recombination | 7 | 52.0× | 9e-09 |
| DNA repair | 7 | 21.3× | 2e-06 |
| DNA damage response | 5 | 12.7× | 8e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
39 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
103 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11374926:CCAGG:C | donor_loss | 1.0000 |
| 19:11374927:CAGGT:C | donor_loss | 1.0000 |
| 19:11374928:AGGT:A | donor_loss | 1.0000 |
| 19:11374930:GT:G | donor_loss | 1.0000 |
| 19:11374931:T:G | donor_loss | 1.0000 |
| 19:11375511:A:AG | acceptor_gain | 1.0000 |
| 19:11375512:G:GG | acceptor_gain | 1.0000 |
| 19:11375512:GAA:G | acceptor_gain | 1.0000 |
| 19:11375512:GA:G | acceptor_gain | 0.9900 |
| 19:11375512:GAAGA:G | acceptor_gain | 0.9900 |
| 19:11375498:T:TA | acceptor_gain | 0.9800 |
| 19:11375507:TTCTA:T | acceptor_loss | 0.9800 |
| 19:11375508:TCTA:T | acceptor_loss | 0.9800 |
| 19:11375509:CTA:C | acceptor_loss | 0.9800 |
| 19:11375510:TAGAA:T | acceptor_gain | 0.9800 |
| 19:11375511:AGA:A | acceptor_loss | 0.9800 |
| 19:11375511:AGAAG:A | acceptor_gain | 0.9800 |
| 19:11375512:G:GC | acceptor_loss | 0.9800 |
| 19:11374930:G:GG | donor_gain | 0.9700 |
| 19:11374780:ACACC:A | donor_gain | 0.9300 |
| 19:11375514:A:AG | acceptor_gain | 0.8700 |
| 19:11375515:G:GA | acceptor_gain | 0.8700 |
| 19:11375513:AAG:A | acceptor_loss | 0.8400 |
| 19:11375514:A:C | acceptor_loss | 0.8400 |
| 19:11375515:GATCC:G | acceptor_gain | 0.7700 |
| 19:11375428:A:T | donor_gain | 0.7500 |
| 19:11375654:G:GT | donor_gain | 0.7400 |
| 19:11375427:G:GT | donor_gain | 0.7200 |
| 19:11374787:G:GT | donor_gain | 0.7000 |
| 19:11374925:TCCAG:T | donor_gain | 0.6800 |
AlphaMissense
1562 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11375523:T:C | F66S | 0.991 |
| 19:11374859:T:C | F39S | 0.980 |
| 19:11374858:T:C | F39L | 0.977 |
| 19:11374860:C:A | F39L | 0.977 |
| 19:11374860:C:G | F39L | 0.977 |
| 19:11375522:T:C | F66L | 0.968 |
| 19:11375524:C:A | F66L | 0.968 |
| 19:11375524:C:G | F66L | 0.968 |
| 19:11374820:C:A | A26D | 0.959 |
| 19:11375528:T:C | Y68H | 0.951 |
| 19:11375517:T:C | I64T | 0.949 |
| 19:11375523:T:G | F66C | 0.948 |
| 19:11375685:A:T | D120V | 0.948 |
| 19:11374853:T:A | V37D | 0.947 |
| 19:11375529:A:G | Y68C | 0.946 |
| 19:11375627:T:C | Y101H | 0.946 |
| 19:11374859:T:G | F39C | 0.945 |
| 19:11375517:T:G | I64S | 0.941 |
| 19:11374777:G:C | G12R | 0.940 |
| 19:11375528:T:G | Y68D | 0.940 |
| 19:11375673:C:A | A116D | 0.940 |
| 19:11375628:A:C | Y101S | 0.938 |
| 19:11375610:T:A | L95H | 0.934 |
| 19:11375822:T:C | C166R | 0.933 |
| 19:11375628:A:G | Y101C | 0.928 |
| 19:11375679:T:G | L118R | 0.927 |
| 19:11375699:T:C | F125L | 0.924 |
| 19:11375701:C:A | F125L | 0.924 |
| 19:11375701:C:G | F125L | 0.924 |
| 19:11375921:T:C | F199L | 0.924 |
dbSNP variants (sampled 300 via entrez): RS1001934794 (19:11373680 C>A), RS1002411022 (19:11374167 G>A), RS1005295343 (19:11376633 T>A,C), RS1005342984 (19:11376187 C>A), RS1005543412 (19:11374978 A>G), RS1005821572 (19:11374019 A>C), RS1005874253 (19:11373747 G>A,C), RS1009265171 (19:11372864 G>A,T), RS1009770471 (19:11374708 A>C), RS1009833186 (19:11374494 T>C), RS1010777082 (19:11376025 G>A,C), RS1010830779 (19:11375705 C>A), RS1010988942 (19:11375916 T>G), RS1013292720 (19:11374410 T>G), RS1013295257 (19:11374064 G>A)
Disease associations
OMIM: gene MIM:614536 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005194_32 | Coronary artery disease | 2.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Methylcholanthrene | affects binding, increases reaction | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.